Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia — Stella

Recruiting

Back to Head and Neck Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill, North Carolina

Key details

Phase

Safety & dosing

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

National Institute of Dental and Craniofacial Research (NIDCR)

Enrollment target

~98 participants

Started

January 2026

Primary completion

February 2030

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov